Inhalation Sciences subsidiary Ziccum awarded 0.5 MSEK from Horizon 2020—the EU’s biggest Research and Innovation program
(STOCKHOLM 18-07-11) The 0.5 MSEK is to help Ziccum develop the scale-up of LaminarPace. The spray drying tool dries vaccines, peptides and biologics at room temperature—transforming them into robust, easy-to-transport dry powders. The technology could lead to the development of a new generation of novel, stable, worldwide therapies, with IP rights built on LaminarPace.It’s the most ambitious Research and Innovation programme the EU has ever launched. Horizon 2020 draws on the expertise of international experts to identify high-potential world-firsts, and grow them from the lab to the